Skip to main content

Thank you for visiting nature.com. You are using a browser version with limited support for CSS. To obtain the best experience, we recommend you use a more up to date browser (or turn off compatibility mode in Internet Explorer). In the meantime, to ensure continued support, we are displaying the site without styles and JavaScript.

The antiapoptotic member of the Bcl-2 family Mcl-1 is a CTL target in cancer patients

This is a preview of subscription content, access via your institution

Relevant articles

Open Access articles citing this article.

Access options

Rent or buy this article

Get just this article for as long as you need it

$39.95

Prices may be subject to local taxes which are calculated during checkout

Figure 1

References

  1. Andersen MH, Svane IM, Kvistborg P, Nielsen OJ, Balslev E, Reker S et al. Immunogenicity of Bcl-2 in cancer patients. Blood 2004, (in press).

  2. Zhou P, Qian L, Bieszczad CK, Noelle R, Binder M, Levy NB et al. Mcl-1 in transgenic mice promotes survival in a spectrum of hematopoietic cell types and immortalization in the myeloid lineage. Blood 1998; 92: 3226–3239.

    CAS  PubMed  Google Scholar 

  3. Krajewska M, Krajewski S, Epstein JI, Shabaik A, Sauvageot J, Song K et al. Immunohistochemical analysis of bcl-2, bax, bcl-X, and mcl-1 expression in prostate cancers. Am J Pathol 1996; 148: 1567–1576.

    CAS  PubMed  PubMed Central  Google Scholar 

  4. Zapata JM, Krajewska M, Krajewski S, Huang RP, Takayama S, Wang HG et al. Expression of multiple apoptosis-regulatory genes in human breast cancer cell lines and primary tumors. Breast Cancer Res Treat 1998; 47: 129–140.

    Article  CAS  PubMed  Google Scholar 

  5. Tang L, Tron VA, Reed JC, Mah KJ, Krajewska M, Li G et al. Expression of apoptosis regulators in cutaneous malignant melanoma. Clin Cancer Res 1998; 4: 1865–1871.

    CAS  PubMed  Google Scholar 

  6. Shangary S, Johnson DE . Recent advances in the development of anticancer agents targeting cell death inhibitors in the Bcl-2 protein family. Leukemia 2003; 17: 1470–1481.

    Article  CAS  PubMed  Google Scholar 

  7. Zhang B, Gojo I, Fenton RG . Myeloid cell factor-1 is a critical survival factor for multiple myeloma. Blood 2002; 99: 1885–1893.

    Article  CAS  PubMed  Google Scholar 

  8. Zhou P, Qian L, Bieszczad CK, Noelle R, Binder M, Levy NB et al. Mcl-1 in transgenic mice promotes survival in a spectrum of hematopoietic cell types and immortalization in the myeloid lineage. Blood 1998; 92: 3226–3239.

    CAS  PubMed  Google Scholar 

  9. Andersen MH, Tan L, Sondergaard I, Zeuthen J, Elliott T, Haurum JS . Poor correspondence between predicted and experimental binding of peptides to class I MHC molecules. Tissue Antigens 2000; 55: 519–531.

    Article  CAS  PubMed  Google Scholar 

  10. Andersen MH, Pedersen LO, Becker JC, thor Straten P . Identification of a cytotoxic T lymphocyte response to the apoptose inhibitor protein survivin in cancer patients. Cancer Res 2001; 61: 869–872.

    CAS  PubMed  Google Scholar 

  11. Scheibenbogen C, Sun Y, Keilholz U, Song M, Stevanovic S, Asemissen AM et al. Identification of known and novel immunogenic T-cell epitopes from tumor antigens recognized by peripheral blood T cells from patients responding to IL-2-based treatment. Int J Cancer 2002; 20: 98:409–98:414.

    Google Scholar 

  12. Moshynska O, Sankaran K, Pahwa P, Saxena A . Prognostic significance of a short sequence insertion in the MCL-1 promoter in chronic lymphocytic leukemia. J Natl Cancer Inst 2004; 96: 673–682.

    Article  CAS  PubMed  Google Scholar 

Download references

Author information

Authors and Affiliations

Authors

Corresponding author

Correspondence to M H Andersen.

Rights and permissions

Reprints and Permissions

About this article

Cite this article

Andersen, M., Becker, J. & thor Straten, P. The antiapoptotic member of the Bcl-2 family Mcl-1 is a CTL target in cancer patients. Leukemia 19, 484–485 (2005). https://doi.org/10.1038/sj.leu.2403621

Download citation

  • Received:

  • Accepted:

  • Published:

  • Issue Date:

  • DOI: https://doi.org/10.1038/sj.leu.2403621

This article is cited by

Search

Quick links